These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 21609390

  • 1. Prediction values of T wave alternans for sudden cardiac death in patients with chronic heart failure: a brief review.
    Zhang X, Ma LL, Yao DK, Wang LX.
    Congest Heart Fail; 2011; 17(3):152-6. PubMed ID: 21609390
    [Abstract] [Full Text] [Related]

  • 2. Predictive power of T-wave alternans and of ventricular gradient hysteresis for the occurrence of ventricular arrhythmias in primary prevention cardioverter-defibrillator patients.
    Man S, De Winter PV, Maan AC, Thijssen J, Borleffs CJ, van Meerwijk WP, Bootsma M, van Erven L, van der Wall EE, Schalij MJ, Burattini L, Burattini R, Swenne CA.
    J Electrocardiol; 2011; 44(4):453-9. PubMed ID: 21704222
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L, Libero L, Pettinati G, Molon G, Curnis A, Occhetta E, Morandi F, Ferrero P, Accardi F, ALPHA Study Group Investigators.
    J Am Coll Cardiol; 2007 Nov 06; 50(19):1896-904. PubMed ID: 17980258
    [Abstract] [Full Text] [Related]

  • 4. Utility of microvolt T-wave alternans to predict sudden cardiac death in patients with cardiomyopathy.
    Chauhan VS, Selvaraj RJ.
    Curr Opin Cardiol; 2007 Jan 06; 22(1):25-32. PubMed ID: 17143041
    [Abstract] [Full Text] [Related]

  • 5. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy.
    Gold MR, Ip JH, Costantini O, Poole JE, McNulty S, Mark DB, Lee KL, Bardy GH.
    Circulation; 2008 Nov 11; 118(20):2022-8. PubMed ID: 18955671
    [Abstract] [Full Text] [Related]

  • 6. Enhanced detection of arrhythmia vulnerability using T wave alternans, left ventricular ejection fraction, and programmed ventricular stimulation: a prospective study in subjects with chronic ischemic heart disease.
    Rashba EJ, Osman AF, Macmurdy K, Kirk MM, Sarang SE, Peters RW, Shorofsky SR, Gold MR.
    J Cardiovasc Electrophysiol; 2004 Feb 11; 15(2):170-6. PubMed ID: 15028046
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The microvolt T-wave alternans test].
    Görmez S, Erciyes D, Gülbaran M.
    Turk Kardiyol Dern Ars; 2010 Sep 11; 38(6):436-43. PubMed ID: 21200127
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction.
    Cantillon DJ, Stein KM, Markowitz SM, Mittal S, Shah BK, Morin DP, Zacks ES, Janik M, Ageno S, Mauer AC, Lerman BB, Iwai S.
    J Am Coll Cardiol; 2007 Jul 10; 50(2):166-73. PubMed ID: 17616302
    [Abstract] [Full Text] [Related]

  • 11. T-wave alternans and the confounding role of the T-wave amplitude.
    Madias JE.
    J Electrocardiol; 2012 Jul 10; 45(3):294-5. PubMed ID: 22265424
    [Abstract] [Full Text] [Related]

  • 12. Letter by Madias regarding article, "Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy".
    Madias JE.
    Circulation; 2009 Jul 21; 120(3):e21; author reply e22. PubMed ID: 19620522
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
    Costantini O, Hohnloser SH, Kirk MM, Lerman BB, Baker JH, Sethuraman B, Dettmer MM, Rosenbaum DS, ABCD Trial Investigators.
    J Am Coll Cardiol; 2009 Feb 10; 53(6):471-9. PubMed ID: 19195603
    [Abstract] [Full Text] [Related]

  • 16. T-wave alternans as a therapeutic marker for antiarrhythmic agents.
    Verrier RL, Nieminen T.
    J Cardiovasc Pharmacol; 2010 Jun 10; 55(6):544-54. PubMed ID: 20555232
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.